DNLI
Denali Therapeutics Inc.
$15.11
-$0.26(-1.69%)
57
Overall
60
Value
58
Tech
55
Quality
Market Cap
$1.86B
Volume
797.61K
52W Range
$10.57 - $33.33
Target Price
$31.67
Key Metrics Overview
| Market Cap | $1.86B | P/E Ratio | N/A |
| 52W High | $33.33 | 52W Low | $10.57 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | -2.5% | 52W Position | 19.9% |
| Overall Score | 57 | Value Score | 60 |
| Quality Score | 55 | Technical Score | 58 |
Growth Analysis
| EPS Current Est | $-3.04 | EPS Next Est | $-2.93 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | DNLI | $15.11 | -1.7% | 797.61K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Denali Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW